Header Logo

Connection

SUSAN BLANEY to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Erlotinib Hydrochloride.
SUSAN BLANEY
Connection Strength
0.020
Erlotinib Hydrochloride
  1. Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Oct 20; 26(30):4921-7.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.